Feng Zhang named Lemelson-MIT Prize winner

Feng Zhang – who will speak at the 2017 BMES Annual Meeting – is the 2017 Lemelson-MIT Prize winner. The award recognizes individuals who translate their ideas into inventions that improve the world in which we live.
Zhang is Pioneer of the revolutionary CRISPR technology and optogenetics.

According to the announcement, shortly after arriving at MIT, Zhang learned about microbial CRISPR-Cas systems and decided to explore their potential for mammalian genome editing. His team was first to harness CRISPR as a tool for genome editing, as described in a landmark paper in Science on January 3, 2013.

The $500,000 Lemelson-MIT Prize is awarded to outstanding mid-career inventors, who have developed a patented product or process of significant value to society, which has been adopted for practical use, or has a high probability of being adopted.

Zhang is scheduled to give the NIBIB Lecture on Friday, October 12 at 5:30 pm at the BMES Annual Meeting in Phoenix. For more information on the meeting please visit: